org placeholder image

Charlotte Heyman

Director of Regulatory Affairs at Edgewise Therapeutics

  • LinkedIn
map
EDGEWISE THERAPEUTICS

EDGEWISE THERAPEUTICS

  • description Description
    Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions....

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Edgewise Therapeutics Org Chart and Mapping

Employees

Maureen Franco

VP Corporate Communications

Bruce Johnson

Vice President, Chemistry, Manufacturing,, Controls

John Wing

Senior Director Medical Affairs

Badreddin Edris

Co-Founder & Board Member

Kevin Koch

President, CEO and CFO

Abby Bronson

VP Patient Advocacy and External Innovation

Sara Cantrell

Senior Research Associate

Frequently Asked Questions Regarding Charlotte Heyman

Answer: Charlotte Heyman works for Edgewise Therapeutics as Director of Regulatory Affairs

Answer: Charlotte Heyman’s role in Edgewise Therapeutics is Director of Regulatory Affairs

Answer: Charlotte Heyman's email address is c***@gmail.com

Answer: Charlotte Heyman's business email address is c****@opusregulatory.com

Answer: Charlotte Heyman’s direct phone number is (***)-***-****

Answer: Charlotte Heyman works in the industry of: Biotechnology

Answer: Charlotte Heyman works Edgewise Therapeutics located at 1715 38th St, Boulder, Colorado, 80301, United States

Answer: Edgewise Therapeutics's Director of Regulatory Affairs is Charlotte Heyman

Answer: Charlotte Heyman contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@opusregulatory.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access